Pet Food and Nutrition

NARA Advocates for Fair Trade Practices in USMCA Review

The North American Renderers Association (NARA) has recently taken a significant step to address trade imbalances affecting the U.S. animal products sector. This overview details NARA's appearance before the U.S. International Trade Commission, highlighting their concerns regarding Mexico's value-added tax on imported U.S. feed ingredients and its broader implications for fair trade under the USMCA agreement.

Ensuring Equitable Trade: NARA's Stand for USMCA Integrity

NARA's Urgent Appeal to U.S. Trade Regulators

On December 3, the North American Renderers Association (NARA) presented its case to the U.S. International Trade Commission. The core of their argument focused on the detrimental impact of Mexico's value-added tax (VAT) on American-sourced feed components, urging the U.S. government to intervene and rectify this trade impediment. NARA's consistent engagement with both the United States Department of Agriculture (USDA) and the Office of the U.S. Trade Representative (USTR) underscores the gravity of this issue, which places U.S. rendering operations and their associated industries at a distinct competitive disadvantage.

The USMCA Review: A Platform for Addressing Trade Discrepancies

This pivotal testimony was delivered during the routine six-year assessment of the United States–Mexico–Canada Agreement (USMCA), held in Washington, D.C. The public forum allowed various stakeholders to articulate their implementation concerns regarding the trade pact. Dana Johnson Downing, NARA's senior vice president overseeing international programs, eloquently articulated NARA's position to key U.S. trade officials, emphasizing the need for robust enforcement of the agreement's principles.

Upholding the Spirit of Free Trade: A Non-Negotiable Imperative

Johnson Downing stressed in her address that the USMCA serves as a fundamental pillar for North American agriculture. She highlighted that the full benefits of this agreement can only be realized if every participating nation adheres faithfully to its commitments, both in letter and spirit. For the animal products industry, she asserted, diligent enforcement is not merely an option but an absolute necessity for its sustained viability and fair operation within the North American market.

Mexico's VAT: A Barrier to Fair Competition

NARA contends that Mexico's ongoing imposition of a 16% VAT on imported animal protein meals and other feed ingredients from the U.S. directly contravenes the USMCA's provisions for market access. These provisions explicitly guarantee duty-free entry for such products. Compounding the issue, similar animal protein meals produced domestically in Mexico are exempt from this tax. This disparity raises significant concerns under USMCA Chapter 2 regarding national treatment and runs contrary to obligations outlined in Article III of the General Agreement on Tariffs and Trade (GATT). NARA interprets this VAT as an indirect tariff, effectively dismantling the equitable trading environment that the USMCA was designed to establish.

The Economic Impact: Threatening Competitiveness and Customer Welfare

Johnson Downing reiterated that this tax operates as a de facto tariff, eroding the fundamental spirit and explicit stipulations of the USMCA. She warned that it imperils the competitive standing of American exports and inflicts direct financial harm upon Mexican clients, many of whom operate with narrow profit margins and are ill-equipped to absorb these additional expenses. The cumulative effect of this tax jeopardizes the economic stability of businesses on both sides of the border.

Advocacy Efforts for Resolving the VAT Dispute

In response to this pressing challenge, Kent Swisher, NARA's president and CEO, along with Johnson Downing, engaged in discussions with leadership at the USDA, USTR, and on Capitol Hill. These meetings aimed to underscore the critical urgency of resolving the VAT issue. They strongly advocated for prioritizing this matter during ongoing U.S.–Mexico negotiations within the comprehensive framework of the USMCA, seeking a resolution that restores fair and balanced trade practice

CBD+CBDA Formula Improves Mobility in Feline Study

A recent scientific investigation has confirmed the positive impact of a specialized cannabidiol (CBD) and cannabidiolic acid (CBDA) mixture on the physical well-being of cats facing challenges in movement. Published in a respected veterinary journal, this rigorous study by ElleVet Sciences provides strong evidence for the therapeutic potential of their unique hemp-derived formulation. The findings indicate a promising advancement in addressing a common issue among feline companions, offering a safe and effective option to enhance their quality of life.

The research involved a meticulously designed randomized, double-blinded, placebo-controlled crossover study where cats experiencing difficulties with mobility were administered either the CBD/CBDA paste or a placebo over a six-week period. The results, corroborated by both veterinary professionals and pet guardians, showed marked improvements in several key indicators of mobility. Cats receiving the active treatment exhibited enhanced gait, better ability to traverse stairs, increased ease in jumping, and a noticeable increase in playful activities. Crucially, comprehensive blood analyses performed after the intervention revealed no adverse safety concerns, underscoring the product's tolerability.

Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR, and chief veterinary medical officer at ElleVet, emphasized the substantial need for reliable long-term solutions for feline mobility. He underscored that the company's research and subsequent product development aim to bridge a significant gap in veterinary care, providing tangible benefits for pets. Haley Israelson, CEO of ElleVet Sciences, reiterated the company's commitment to a science-first approach in meeting the unique requirements of cats. She expressed enthusiasm for the study's publication, highlighting its role in broadening the array of supportive treatments available for felines, thereby enriching the lives of both cats and their human families.

The dedication to scientific rigor and innovation shown in this study paves the way for a future where pet well-being is continually elevated through evidence-based solutions. It reflects a compassionate understanding of animals' needs and a proactive effort to provide them with happier, more active lives, fostering a deeper bond between pets and their owners.

See More

PhytoGaia to Research PetGaia's Impact on Canine Skin and Coat Health

PhytoGaia, a company specializing in pet supplements, has initiated an eight-week clinical investigation to explore the benefits of its PetGaia product on canine skin and coat vitality. This rigorous study, conducted in collaboration with a Malaysian contract research organization, aims to generate robust scientific data to support PetGaia's efficacy claims, providing valuable insights for pet food manufacturers and formulators.

The comprehensive study will meticulously assess various aspects of skin and coat health in companion dogs receiving oral supplementation of PetGaia. Key metrics include the evaluation of skin issues such as redness, dryness, itchiness, and the formation of lesions. Furthermore, researchers will analyze improvements in coat attributes like shine, softness, shedding, and overall smoothness, providing a holistic view of the product's impact.

PetGaia is a distinctive extract derived from palm fruit, rich in beneficial compounds such as tocotrienols, alpha-tocopherol, plant-based squalene, and phytosterols. The extraction process is notably environmentally friendly, employing non-chemical, non-solvent, and non-biodiesel methods, underscoring PhytoGaia's commitment to natural and sustainable solutions.

Dr. Ariati Aris, a scientific affairs specialist at PhytoGaia, emphasized the importance of this controlled study. She stated that the goal is to produce strong, evidence-based results concerning PetGaia's effects on canine skin. She highlighted that working with a reputable contract research organization ensures the scientific integrity of the trial, yielding findings that can confidently guide product development and substantiation of claims for formulators and manufacturers.

Prior research on rodents has demonstrated the protective effects of dietary tocotrienols against oxidative stress in the skin and their role in promoting hair follicle regeneration. Human studies have also indicated that oral tocotrienol supplementation can lead to improvements in hair density and scalp health, alongside a reduction in adverse reactions such as erythema, edema, itching, and blistering, when compared to control treatments.

Bryan See, PhytoGaia's vice president, shared his personal motivation for supporting this research. As a dog owner, he has observed firsthand the challenges of sensitive skin in his own pets, particularly his French Bulldog, who is prone to food sensitivities and coat problems. This personal connection drives his enthusiasm for the study, viewing PetGaia as a natural and scientifically supported approach to enhancing skin and coat health. He looks forward to the study's outcomes and how they will benefit both pets and the brands that incorporate PetGaia into their products.

This clinical trial represents a significant step forward in understanding the potential of natural ingredients to improve pet health, offering a promising solution for maintaining optimal skin and coat conditions in dogs.

See More